Top

Category: Manufacturing


Industry, Manufacturing, Research and Development, Vaccines

EU governments pressure manufacturers to renegotiate contracts for COVID-19 vaccines

June 15, 2022

Via: PMLiVE

When vaccines became available earlier in the COVID-19 pandemic, countries vied for supply contracts. However, as the need for vaccines begins to slow in Europe, some countries want to amend their contracts to reduce spending and to prevent receiving more […]


Manufacturing, Research and Development

Alnylam wins FDA approval of rare disease drug in step toward profitability

June 14, 2022

Via: Biopharma Dive

Alnylam, a pioneer in the drugmaking method known as RNA interference, has climbed the biotech industry ranks over the last two decades. After solving challenges associated with delivering these treatments into the body, Alnylam has become one of the sector’s […]


Manufacturing, Research and Development

Resilience, a well-funded manufacturing startup, joins with the Parker Institute to make cancer drugs

June 9, 2022

Via: Biopharma Dive

While recent years have seen scientists make major advances in cutting-edge treatments such as gene and cell therapies, manufacturing remains a significant hurdle. The complex, multi-step processes required are beyond the capabilities of a traditional pharmaceutical plant. That’s where Resilience […]


Cell and Gene Therapy, Industry, Manufacturing, Research and Development

Regenxbio Opens Gene Therapy Manufacturing Facility

June 9, 2022

Via: Contract Pharma

Regenxbio recently celebrated the opening of its new Manufacturing Innovation Center gene therapy manufacturing facility. “Launching operations at our Manufacturing Innovation Center is an important milestone in the evolution of REGENXBIO,” said Kenneth T. Mills, president and CEO of REGENXBIO. […]


Manufacturing, Research and Development

Sana Biotechnology ditches California manufacturing plans in bid to save $100M

June 2, 2022

Via: FiercePharma

Sana Biotechnology, which raised a whopping $588 million in its initial public offering last year, has inked a deal for new manufacturing space. The preclinical-stage biotech is ditching plans to run its manufacturing operations in Fremont, California, and instead plans […]


Manufacturing, Research and Development

Catalent Introduces UpTempo Virtuoso Platform

May 16, 2022

Via: Contract Pharma

Catalent, a company enabling biopharma, cell, gene and consumer health partners to optimize development, launch, and supply of better patient treatments across multiple modalities, has introduced its new, UpTempo Virtuoso platform process for the development and CGMP manufacturing of adeno-associated […]


FDA, Manufacturing, Regulations, Research and Development

FDA plans study into how patients and physicians make prescription decisions

April 25, 2022

Via: FiercePharma

The FDA’s Office of Prescription Drug Promotion (OPDP) wants to find out how patients and physicians weigh the tradeoffs between risks and benefits when starting a new prescription drug. What characteristics influence treatment choices and how do people reach the […]


Manufacturing, Research and Development

Catalent to Invest $350 Million in Manufacturing Facility in Bloomington, Indiana

April 22, 2022

Via: Biopharm International

Catalent announced on April 21, 2022 that it is planning a multi-year $350 million investment at its facility in Bloomington, Ind. to expand its biologics drug substance and drug product manufacturing capabilities. The project will include the additions of new […]


Manufacturing, Research and Development

Seagen to expand, add jobs with new cancer drug factory

April 21, 2022

Via: Biopharma Dive

Formerly known as Seattle Genetics, Seagen has grown to become one of the industry’s largest biotechs, with a market value of $26 billion. Seagen’s business is built on antibody drug conjugates, or ADCs, a type of medicine that uses laboratory-engineered […]


Manufacturing, Research and Development

Enzyvant to build regenerative medicine manufacturing plant in North Carolina

April 21, 2022

Via: FiercePharma

Enzyvant, which focuses on developing regenerative medicines for rare diseases, has laid out plans to build a new manufacturing facility in the Research Triangle Park area of North Carolina. Construction of the 25,972 square-foot plant is set to begin this […]


Cell and Gene Therapy, Industry, Manufacturing, Research and Development

VectorBuilder to Expand with $500 Million Gene Delivery Research and Manufacturing Campus

April 13, 2022

Via: Biopharm International

VectorBuilder, a global gene delivery solutions company, announced on April 11, 2022 the construction of a new $500 million R&D and manufacturing center in Guangzhou, China. The ‘Gene Delivery Research and Manufacturing Campus’ will aid in the growth of the […]


Manufacturing, Research and Development

Catalent Acquires Vaccine Manufacturing Innovation Centre in Harwell, Oxford

April 7, 2022

Via: Biopharm International

Catalent announced on April 6, 2022 that it has acquired Vaccine Manufacturing and Innovation Centre UK Limited’s biologics development and manufacturing facility currently under construction near Oxford, United Kingdom. Catalent plans to invest up to US$160 million (£120 million) into […]